2003
DOI: 10.1046/j.1443-9506.2003.01776.x
|View full text |Cite
|
Sign up to set email alerts
|

Long-term effects of policosanol on older hypertensive patients with type II hypercholesterolemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
7
0

Year Published

2005
2005
2020
2020

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 0 publications
1
7
0
Order By: Relevance
“…However, HDL cholesterol was similar among experimental groups and control group. This may be partly attributable to that octacosanol regulate some enzymatic activities in lipid metabolism (Kato et al, 1995 andMas et al, 2004 ). These results were agreement with Peng et al (2016) who reported that a significant decrease of these traits by dietary supplementation of octacosanol in the diet of laying hens at levels of 18 mg or 27 mg octa /kg diet.…”
Section: Blood Traitssupporting
confidence: 85%
“…However, HDL cholesterol was similar among experimental groups and control group. This may be partly attributable to that octacosanol regulate some enzymatic activities in lipid metabolism (Kato et al, 1995 andMas et al, 2004 ). These results were agreement with Peng et al (2016) who reported that a significant decrease of these traits by dietary supplementation of octacosanol in the diet of laying hens at levels of 18 mg or 27 mg octa /kg diet.…”
Section: Blood Traitssupporting
confidence: 85%
“…The ratio of TC/HDL-C was lowered by 27.1% and 27.5%, while HDL-C levels increased by 17.6% and 17.0%, respectively. In a recent study, Mas et al [28] reported that policosanol lowered LDL-C (29.5 %), TC (21.9 %), TG (16.9 %) and raised HDL-C (12.4 %) in older patients with type 2 DM. In addition, a few short-term studies indicated that the cholesterol-lowering effect of policosanol was better than that of statins such as simvastatin, pravastatin, lovastatin, probucol, or acipimox and with fewer side effects in patients with type II HC [27][28][29][30].…”
Section: Essential Alcohols: Policosanolmentioning
confidence: 95%
“…In a recent study, Mas et al [28] reported that policosanol lowered LDL-C (29.5 %), TC (21.9 %), TG (16.9 %) and raised HDL-C (12.4 %) in older patients with type 2 DM. In addition, a few short-term studies indicated that the cholesterol-lowering effect of policosanol was better than that of statins such as simvastatin, pravastatin, lovastatin, probucol, or acipimox and with fewer side effects in patients with type II HC [27][28][29][30]. Prat et al [31], Crespo et al [32] and Noa et al [33] reported that policosanol reduces intermittent claudication [27,34], platelet aggregation [35,36], diastolic blood pressure [DBP] and systolic blood pressure [SBP] [37,38] in older patients with hypertension and type II HC and dyslipidemia in type 2 DM [27,39]; and cerebral ischemia in animals [40].…”
Section: Essential Alcohols: Policosanolmentioning
confidence: 95%
“…The studies varied in duration and sample population, and consistently showed reductions in serum LDL-C and TC levels of up to 44% and 29%, respectively (Crespo et al, 1997). Significant increases in serum HDL-C as compared to placebo were only reported in a few studies (Menendez et al, 1999b;Castano et al, 2001a;Mirkin et al, 2001) and reductions in serum triglycerides in only two (Castano et al, 2002c;Mas et al, 2004).The lipid-lowering potential of SCP tended to increase in a dose-dependant manner up to 20 mg/day. Beyond this dose, no further cholesterol reductions were observed, as reported in 2001 by…”
Section: Human Studies Investigating Policosanol Efficacymentioning
confidence: 98%